Nexa Orthopedics was founded in 2004 by HealthpointCapital to create the preeminent company in extremities surgery through a program of business acquisitions, technology in-licensing and internal product development. The company is based in San Diego, California with subsidiary operations in Grenoble, France.

VISION
The extremities orthopedics market has historically been highly fragmented, under capitalized and lacked true industry leadership. Nexa Orthopedics will become the technology leader in extremities orthopedics, bringing to market new products that improve clinical practice and patient outcomes.

STRATEGY
Nexa is pursing a strategy to assemble an operating platform and distribution network through the acquisition of quality niche extremities companies; to in-license emerging core technologies with game changing potential in extremities surgery; and to empanel thought leader advisory boards to consult on strategy and partner in product development.

EXECUTION
Nexa's management team, with over 80 years combined experience and a track record of success in business development, began to build a market-leading portfolio in early 2005 with the acquisition of Futura Biomedical. The company has since strengthened its offering through the acquisitions of the StayFuse interphalngeal fusion product line, and BIOProfile S.A., a leading developer of pyrocarbon implant technology. It also formed a strategic alliance with OsteoBiologics, Inc. for exclusive rights to distribute its PolyGraft® products to extremity surgeons. Nexa is integrating these new technologies into a complete product portfolio and is building a premier sales and physician training organization. Finally, Nexa established a scientific advisory board encompassing thought-leading orthopedic foot and ankle surgeons, hand surgeons, and podiatric surgeons.